REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,020
+150 (1.26%)
At close: Dec 5, 2025

REYON Pharmaceutical Market Cap

REYON Pharmaceutical has a market cap or net worth of 220.46 billion as of December 5, 2025. Its market cap has decreased by -24.07% in one year.

Market Cap
220.46B
Enterprise Value
426.16B
Revenue
149.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
12,020.00

Market Cap Chart

Since June 10, 2010, REYON Pharmaceutical's market cap has increased from 164.55B to 220.46B, an increase of 33.97%. That is a compound annual growth rate of 1.91%.

History

DateMarket Cap% Change
Dec 5, 2025220.46B-6.39%
Dec 30, 2024235.50B-22.37%
Dec 28, 2023303.36B-21.07%
Dec 29, 2022384.35B-39.10%
Dec 30, 2021631.11B61.64%
Dec 30, 2020390.43B47.64%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 75.96T
Celltrion 40.11T
ALTEOGEN 24.41T
ABL Bio 10.51T
SK Biopharmaceuticals 10.49T
Yuhan 8,755.13B
LigaChem Biosciences 6,753.15B
Peptron 6,645.44B
Market Cap Rankings